Reduced skeletal muscle mass leads to reduced target tissue for insulin action, decreased sensitivity to insulin action, and skeletal muscle insulin resistance, resulting in reduced skeletal muscle glucose uptake and impaired glucose phosphorylation, resulting in impaired skeletal muscle mitochondrial function and metabolic disorders. Here, INS is linked to metabolic disease.